60
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Development and early experiences of a Swedish psoriatic arthritis register

, &
Pages 221-225 | Published online: 12 Jul 2009
 

Abstract

Objectives : To present a programme for a psoriatic arthritis (PsA) register (SwePsA) and to report the early experiences of a test period. Methods : Patients with symptoms and/or signs consistent with PsA or resembling PsA are enrolled into a follow-up programme, provided the disease duration at inclusion is not longer than two years. Results : Ninety-two patients were included into the programme during the test period. Sixty patients were classified as having PsA, 39 mono/oligoarticular, 19 polyarticular and two predominant axial. Thirty-two patients were classified as possible PsA. Thirty-two of the 92 included patients were followed for one year. Seven of 18 with mono/oligoarticular PsA had advanced to polyarticular PsA. Four of nine patients initially classified as possible PsA evolved into definite polyarticular PsA. Patients with polyarticular PsA had evidence of more severe disease than had patients with mono/oligoarticular PsA. Conclusions : The programme was easy to administrate and not very time-consuming in daily clinical practice. The preliminary experiences emphasize the importance of early diagnosis and the need for reliable outcome predictors for this potentially severe disorder.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.